# National Multiple Sclerosis Society

National Multiple Sclerosis Society is a Foundation based in Denver, United States.

## Overview

- **Organization type:** Foundation
- **Headquarters:** Denver, United States
- **Region:** North America
- **Address:** Denver, CO, United States
- **Founded:** 1946
- **Assets under management:** Undisclosed
- **Website:** nationalmssociety.org

## Regulatory record

- **Reports private funds:** No

## About

The National MS Society is a collective of individuals working to end multiple sclerosis. MS stops people from moving. The organization has made five investments, including a March 13, 2025, grant to Myrobalan Therapeutics as part of its Grant - II.

## Sectors

- Healthcare Services
- Nonprofit

## Questions

### Who runs investment decisions at the National Multiple Sclerosis Society?

The NMSS has a Chief Executive Officer (CEO) who oversees operations, including financial strategy. As of public record, the CEO is Cyndi Zagieboylo (retired in 2024) succeeded by Dr. Patrick Killian in 2024 (per NMSS press releases). Investment decisions are made by the society's Finance Committee, Board of Trustees, and professional investment advisors, though specific CIO-level names are not publicly disclosed.

### How does the National Multiple Sclerosis Society source research projects?

The NMSS uses a competitive, peer-reviewed grant process to fund research. It issues requests for proposals (RFPs) in focus areas like progressive MS, repair mechanisms, and clinical trials. The society also partners with academic institutions and pharmaceutical companies through collaborative research agreements (per NMSS research program descriptions).

### What investment stages does the National Multiple Sclerosis Society typically target?

The NMSS is not an investment firm; it focuses on funding research across the spectrum from early discovery to late-stage translational studies, including pilot grants, multi-year research contracts, and clinical trial support. It does not target venture stages, but rather scientific milestones in MS-related research and care.

### Which sectors does the National Multiple Sclerosis Society explicitly avoid?

The NMSS avoids funding outside its mission: it does not invest in for-profit ventures as a primary activity, nor does it fund research unrelated to multiple sclerosis or the central nervous system. Its investment portfolio follows standard nonprofit endowment guidelines, avoiding speculative or high-risk assets to preserve capital for mission programs.

## Related profiles

- [Dingman Center Angels](https://altss.com/profile/dingman-center-angels)
- [TerrAscend Corp.](https://altss.com/profile/terrascend-corp)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/national-multiple-sclerosis-society

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology